ARAY ACCURAY INC

Nasdaq accuray.com


$ 1.18 $ 0.00 (0 %)    

Monday, 10-Nov-2025 16:17:28 EST
QQQ $ 624.19 $ 4.38 (0.71 %)
DIA $ 473.96 $ 1.94 (0.41 %)
SPY $ 681.97 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 379.60 $ 2.40 (0.64 %)
$ 1.17
$ 1.16
$ 1.18 x 2,244
$ 1.22 x 8,000
$ 1.16 - $ 1.21
$ 1.10 - $ 2.95
1,061,810
na
132.61M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-28-2025 06-30-2025 10-K
3 05-02-2025 03-31-2025 10-Q
4 02-05-2025 12-31-2024 10-Q
5 11-06-2024 09-30-2024 10-Q
6 09-19-2024 06-30-2024 10-K
7 05-08-2024 03-31-2024 10-Q
8 02-07-2024 12-31-2023 10-Q
9 11-07-2023 09-30-2023 10-Q
10 09-07-2023 06-30-2023 10-K
11 05-08-2023 03-31-2023 10-Q
12 02-02-2023 12-31-2022 10-Q
13 11-03-2022 09-30-2022 10-Q
14 08-17-2022 06-30-2022 10-K
15 04-29-2022 03-31-2022 10-Q
16 01-28-2022 12-31-2021 10-Q
17 11-04-2021 09-30-2021 10-Q
18 08-17-2021 06-30-2021 10-K
19 04-30-2021 03-31-2021 10-Q
20 02-01-2021 12-31-2020 10-Q
21 11-04-2020 09-30-2020 10-Q
22 08-25-2020 06-30-2020 10-K
23 05-08-2020 03-31-2020 10-Q
24 02-04-2020 12-31-2019 10-Q
25 11-06-2019 09-30-2019 10-Q
26 08-23-2019 06-30-2019 10-K
27 05-09-2019 03-31-2019 10-Q
28 02-08-2019 12-31-2018 10-Q
29 11-06-2018 09-30-2018 10-Q
30 08-24-2018 06-30-2018 10-K
31 05-02-2018 03-31-2018 10-Q
32 02-05-2018 12-31-2017 10-Q
33 11-03-2017 09-30-2017 10-Q
34 08-25-2017 06-30-2017 10-K
35 05-05-2017 03-31-2017 10-Q
36 02-03-2017 12-31-2016 10-Q
37 11-01-2016 09-30-2016 10-Q
38 08-24-2016 06-30-2016 10-K
39 04-29-2016 03-31-2016 10-Q
40 02-01-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-accuray-lowers-price-target-to-4

BTIG analyst Marie Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and lowers the price target from $5 to $4.

 accuray-affirms-fy2026-sales-guidance-of-471000m-485000m-vs-475150m-est

Accuray (NASDAQ:ARAY) affirms FY2026 sales outlook from $471.000 million-$485.000 million to $471.000 million-$485.000 million ...

 accuray-q1-eps-016-misses-006-estimate-sales-93942m-beat-91350m-estimate

Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.06) by ...

 accuray-reports-preliminary-q1-fy26-revenue-of-925m-94m-product-sales-lag-in-eimea-and-china-ebitda-at-4m

Fiscal 2026 First Quarter Financial ResultsAccuray expects to release summary financial information for its fiscal 2026 first q...

 accuray-appoints-steve-la-neve-as-ceo-effective-immediately-succeeding-suzanne-winter

Accuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational ...

 accuray-announces-first-patients-treated-through-5d-clinics-in-melbourne-using-cyberknife-s7-system

5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Ra...

 accuray-and-uw-smph-sign-mou-to-advance-online-adaptive-radiotherapy-on-accuray-helical-radiation-treatment-delivery-platform

Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced tod...

 accuray-inc-advances-adaptive-radiotherapy-with-introduction-of-accuray-stellar-solution

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive ...

 btig-maintains-buy-on-accuray-raises-price-target-to-5

BTIG analyst Maria Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and raises the price target from $4 to $5.

 accuray-sees-fy2026-sales-471000m-485000m-vs-454740m-est

Accuray (NASDAQ:ARAY) sees FY2026 sales of $471.000 million-$485.000 million vs $454.740 million analyst estimate.

 accuray-q4-eps-001-misses-002-estimate-sales-127543m-beat-123774m-estimate

Accuray (NASDAQ:ARAY) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 44...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION